The Teratoma Assay: An In Vivo Assessment of Pluripotency

Methods in Molecular Biology

Volumn 767, Issue , 2011, Pages 231-241

  Wesselschmidt, Robin L ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

embryonic stem cells; kidney capsule teratoma; pluripotency assay; pluripotent stem cells; teratoma; testis capsule teratoma

Indexed keywords

ANIMAL; ARTICLE; CYTOLOGY; HUMAN; IMPLANT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY; PLURIPOTENT STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION; TERATOMA; TESTIS; TISSUE CULTURE TECHNIQUE;

ANIMALS; HUMANS; IMPLANTS, EXPERIMENTAL; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MALE; MICE; PLURIPOTENT STEM CELLS; TERATOMA; TESTIS; TISSUE CULTURE TECHNIQUES;

MAMMALIA;

EID: 80054765586     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-201-4_17     Document Type: Chapter

References (22)

1. Smith KP, Luong MX, Stein GS (2009). Pluripotency: Toward a gold standard for human ES and iPS cells. J of Cellular Physiol. 220, 21–29.
2. Przyborski S. A (2005). Differentiation of human embryonic stem cells after transplantation in immune-deficient mice. Stem Cells 23, 1242–50.
3. Andrews PW, Przyborski SA, Thomson JA (2001). Embryonal carcinoma cells as embryonic stem cells. Stem Cell Biology. Editors: Marshak DR, Gardner RL, Gottlieb D. New York: Cold Spring Harbor Laboratory Press. pp 231–265
4. Wesselschmidt RL (2007). Generation of human embryonic stem cell derived teratomas. Human Stem Cell Manual: A Laboratory Guide. First Edition. Editors: Loring JF, Wesselschmidt RL, and Schwartz PH. New York, London, San Diego: Elsevier. pp 162–170
5. Damjanov I and Ährlund-Richter L (2007). Characterization of human embryonic stem cell derived teratomas. In Human Stem Cell Manual: A Laboratory Guide. Human Stem Cell Manual: A Laboratory Guide. First Edition. Editors: Loring JF, Wesselschmidt RL, and Schwartz PH. New York, London, San Diego: Elsevier. pp 171–182
6. Gertow K, Przyborski S, Loring JF, Auerbach JM, Epifano O, Otonkoski T, Damjanov I, Ahrlund-Richter L (2007). Isolation of human embryonic stem cell derived teratomas for the assessment of pluripotency. Curr Protoc Stem Cell Biol 3: Unit 1B.4 (1–29).
7. Cooke MJ, Stojkovic M, Przyborski SA (2006). Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site. Stem Cells and Dev 15:254–259.
8. Cao F, van der Bogt KEA, Sadrzadeh A, Xie X, Sheikh AY, Wang H, Connolly AJ, Robbins RC, Wu JC (2007). Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells and Dev. 16: 883–892.
9. Shih CC, Forman SJ, Chu P, Slovak M (2007). Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted fetal tissues in severe combined immunodeficient mice. Stem Cells and Dev. 16: 893–902.
10. Prokhorova TA, Harkness LM, Frandsen U, Ditzel N, Schroder HD, Burns JS, Kassem M (2009). Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. Stem Cells and Dev. 18: 47–54
11. Lee AS, Tang C, Cao F, Xiaoyan X, van der Bogt K, Hwang A, Connolly AG, Robbins RC, Wu JC (2009). Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 8: 2608–2612.
12. International Stem Cell Initiative (2007) Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechol 25:803–816.
13. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–47
14. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotech. 19, 971–74.
15. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian Shulan T, Nie J, Jonsdottier GA, Routti V, Stewart R, Slukvin II, Thomson JA (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917–1920.
16. Rubenoff BE, Pera MF, Fong C-Y, Trouson A, Bongso A (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotech. 18, 399–404.
17. Richards M, Fong CY, Tan S, Chan WK, Bongso A (2004). An efficient and safe xeno-free cryopreservation method for the storage of human embryonic stem cells. Stem Cells 22: 779–89.
18. Hovatta O, Mikkola M, Gertow K, Stromberg AM, Inzunza J, Hreinsson J, Rozell B, Blennow E, Andang M, Arhlund-Richter L (2003). A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod 18: 1404–1409.
19. nd edition) Editors: Hogan, Beddington, Constantinti, Lacy. Cold Spring Harbor New York: Cold Spring Harbor Press.
20. Gertow K, Wolbank S, Rozell B, et al. (2004) Organized development from human embryonic stem cells after injection into immunodeficient mice. Stem Cells Dev 13: 421–435.
21. Oh SKW, Chua P, Foon KL, Ng E, Chin A, Choo ABH, Srinivasan R (2009). Quantitative identification of teratoma tissues formed by human embryonic stem cells with TeratomEye. Biotechnol Lett 31, 653–58.
22. Zeller W, Meier G, Bürki K, Panoussis B (1998). Adverse effects of tribromoethanol as used in the production of transgenic mice. Lab Anim. 132: 407–13.